A Phase I Study to Assess LBL-047 in Healthy Adults and Patients With Systemic Lupus Erythematosus

NCT07323173 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

112

Enrollment

INDUSTRY

Sponsor class

Conditions

Systemic Lupus Erythematosus

Interventions

DRUG: LBL-047 for Injection
DRUG: LBL-047 placebo for injection

Sponsor

Nanjing Leads Biolabs Co.,Ltd

Collaborators

[object Object]
[object Object]